Changes in the developmental status of preschoolers with sickle cell disease

Julia D Johnston1, Jeffrey Schatz1, Sarah E Bills1

  • 1Department of Psychology, University of South Carolina, Columbia, South Carolina.

Pediatric Blood & Cancer
|February 7, 2022
PubMed

Insights

Regular developmental screening is crucial for children with sickle cell disease. Early detection of developmental delays, especially after cerebrovascular complications, can guide interventions and improve outcomes.

Area of Science:

  • Pediatrics
  • Neurology
  • Genetics

Background:

  • Developmental monitoring and screening are key for identifying children with sickle cell disease (SCD) at risk for cerebrovascular complications.
  • Limited data exist on longitudinal changes in developmental screenings for these children.
  • Cerebrovascular complications in SCD can significantly impact neurodevelopment.

Purpose of the Study:

  • To examine longitudinal developmental screening outcomes in children with sickle cell disease.
  • To investigate the relationship between cerebrovascular complications and developmental delay.
  • To assess the impact of formal developmental interventions.

Main Methods:

  • Longitudinal study of 43 children with sickle cell disease.
  • Ages and Stages Questionnaire, 2nd edition (ASQ-2) used for screening at ages two and four.
  • Analysis of screening outcome stability and prediction of developmental delay by cerebrovascular events.

Main Results:

  • Two-thirds of children exhibited stable developmental screening outcomes over time.
  • New-onset cerebrovascular complications significantly predicted the emergence of developmental delay (P = 0.017).
  • Multivariate analysis indicated a potential benefit from formal developmental interventions.

Conclusions:

  • Regular developmental screening throughout the preschool years is essential for detecting changes in developmental status in children with SCD.
  • Early identification of developmental delays linked to cerebrovascular complications can inform timely interventions.
  • Longitudinal monitoring is vital for understanding neurodevelopmental trajectories in pediatric sickle cell disease.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Introduction to Developmental Psychology01:27

Introduction to Developmental Psychology

Developmental psychology explores the changes and continuities in human abilities throughout life, encompassing physical, cognitive, linguistic, and social dimensions. Human development is not restricted to growth, but includes aspects of decline, particularly in physical abilities as individuals age. Developmental psychologists seek to understand how people change as they age and how their mental and social skills evolve.Developmental MilestonesA key concept in developmental psychology is...
677
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
35.7K